We propose that the anti-CXCR3 antibody treatment alleviates inflammatory cell infiltration and further reduces inflammatory cytokine production after CVA2 infection, which finally prevents the subsequent destruction of the organs or tissues from uncontrollable cell-mediated autoimmunity (50). The gene discussed is CXCR3; the disease is Autoimmunity.